C. Muhinda, J. Kabahizi, K. Bazatsinda, N. Dukuze, C. Nsanzabaganwa, G. Murenzi, M. Yotebieng, B. Bagaya, L. Mutesa
{"title":"Evaluation of immunological response to hepatitis B vaccine among healthcare workers at Rwanda Military Hospital","authors":"C. Muhinda, J. Kabahizi, K. Bazatsinda, N. Dukuze, C. Nsanzabaganwa, G. Murenzi, M. Yotebieng, B. Bagaya, L. Mutesa","doi":"10.4314/rmj.v80i3.8","DOIUrl":null,"url":null,"abstract":"
 
 
 
 
 
 INTRODUCTION: Healthcare workers (HCWs) are at high risk of acquiring hepatitis B viral (HBV) infection through occupational exposure to blood or body fluids. However, the rates of non- responders after HBV vaccination among HCWs are not well documented. Therefore, we aimed to determine the proportion of immunological non-responders among HCWs who received Hepatitis B vaccine at Rwanda Military Hospital (RMH) and characterize the memory T cell responses to the Hepatitis B vaccine.
 METHODS: A cross sectional study was conducted at the RMH. HBV vaccinated HCWs were evaluated for immune response by measuring serum Hepatitis B surface antibody (anti-HBs) titers and levels of HB core antibodies (HBcAb) on COBAS e411 machine, 6 years post vaccination.RESULTS: Initially 87 employees were included in the study. Four participants were excluded due to incomplete records. 52 (62.7%) participants were female and 31 (37.3%) were male. HWCs’ age ranged between 23 and 66 years with a mean (±SD) age of 38.2 ± 7.3. Of 83 HCWs, 70 (84.3%)showed response to HBV vaccine, non-responders were 11 (13.3%) and 2 (2.4%) showed immunity due to natural infection. There was no significant difference in Th cell frequencies and function between responders and non-responders after stimulation with rHBsAg vaccine.
 CONCLUSION: Immunological response six years post HBsAg vaccination was 84.3% in HCWs at RMH and similar to the global prevalence. Anti-HBs levels should be tested in all HCWs following HBsAg vaccination. Personal protective equipment, and a dose of Hepatitis B prophylaxis when exposed should be emphasized.
 
 
 
 
 
","PeriodicalId":38181,"journal":{"name":"Rwanda Medical Journal","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rwanda Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/rmj.v80i3.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
INTRODUCTION: Healthcare workers (HCWs) are at high risk of acquiring hepatitis B viral (HBV) infection through occupational exposure to blood or body fluids. However, the rates of non- responders after HBV vaccination among HCWs are not well documented. Therefore, we aimed to determine the proportion of immunological non-responders among HCWs who received Hepatitis B vaccine at Rwanda Military Hospital (RMH) and characterize the memory T cell responses to the Hepatitis B vaccine.
METHODS: A cross sectional study was conducted at the RMH. HBV vaccinated HCWs were evaluated for immune response by measuring serum Hepatitis B surface antibody (anti-HBs) titers and levels of HB core antibodies (HBcAb) on COBAS e411 machine, 6 years post vaccination.RESULTS: Initially 87 employees were included in the study. Four participants were excluded due to incomplete records. 52 (62.7%) participants were female and 31 (37.3%) were male. HWCs’ age ranged between 23 and 66 years with a mean (±SD) age of 38.2 ± 7.3. Of 83 HCWs, 70 (84.3%)showed response to HBV vaccine, non-responders were 11 (13.3%) and 2 (2.4%) showed immunity due to natural infection. There was no significant difference in Th cell frequencies and function between responders and non-responders after stimulation with rHBsAg vaccine.
CONCLUSION: Immunological response six years post HBsAg vaccination was 84.3% in HCWs at RMH and similar to the global prevalence. Anti-HBs levels should be tested in all HCWs following HBsAg vaccination. Personal protective equipment, and a dose of Hepatitis B prophylaxis when exposed should be emphasized.
期刊介绍:
The Rwanda Medical Journal (RMJ), is a Not-For-Profit scientific, medical, journal that is published entirely online in open-access electronic format. The RMJ is an interdisciplinary research journal for publication of original work in all the major health disciplines. Through a rigorous process of evaluation and peer review, The RMJ strives to publish original works of high quality for a diverse audience of healthcare professionals. The Journal seeks to deepen knowledge and advance scientific discovery to improve the quality of care of patients in Rwanda and internationally.